GFC Diagnostics Ltd.
GFC Diagnostics was formed in 2007 to promote and develop the SmokeScreen and other SafeTube products. The initial invention and development was carried out in the University of Birmingham. This work was supported by the UK`s Department of Health. The management of GFC Diagnostics works closely with all end-users to ensure optimal use of the SmokeScreen and other products. We are closely affiliated with the Life Insurance Industry, with public and private healthcare providers, with medical and surgical research groups in the UK and around the world. Over the past year the company has embarked on an R & D programme to develop rapid, easy to use tests for point of care situations culminating in a test for detection of MRSA within 30 minutes that has been shown to work on cultured samples. The programme is being extended into a clinical evaluation of the test and with plans to broaden the programme to detect other bacteria associated with antibiotic resistance.